FUSED-RING COMPOUNDS AND USE THEREOF AS DRUGS

Title:

FUSED-RING COMPOUNDS AND USE THEREOF AS DRUGS

Document Type and Number:

WIPO Patent Application WO/2001/047883

Kind Code:

A1

Abstract:

Fused-ring compounds represented by general formula [I] or the like, or pharmaceutically acceptable salts thereof; and hepatitis C remedies containing the compounds or salts: [I] (wherein each symbol is as defined in the description). The above compounds and salts exhibit an anti-HCV (hepatitis C virus) activity by virtue of their inhibitory activity against HCV polymerase, thus being useful as therapeutic or preventive agents for hepatitis C.

Inventors:

HASHIMOTO HIROMASA (JP)
MIZUTANI KENJI (JP)
YOSHIDA ATSUHITO (JP)

Application Number:

PCT/JP2000/009181

Publication Date:

July 05, 2001

Filing Date:

December 22, 2000

Export Citation:

Click for automatic bibliography generation Help

Assignee:

JAPAN TOBACCO INC (JP)
HASHIMOTO HIROMASA (JP)
MIZUTANI KENJI (JP)
YOSHIDA ATSUHITO (JP)

International Classes:

A61K31/42; A61K31/427; A61K31/437; A61K31/4439; A61K31/4523; A61K31/496; A61K31/519; A61K31/52; A61K31/53; A61K31/55; A61K31/7076; A61P1/16; A61P31/20; C07D235/18; C07D235/30; C07D401/04; C07D401/10; C07D401/12; C07D401/14; C07D403/04; C07D403/12; C07D405/04; C07D405/12; C07D409/04; C07D409/12; C07D409/14; C07D413/04; C07D413/12; C07D417/12; C07D495/04; C07D521/00; A61K31/4184; (IPC1-7): C07D209/12; C07D235/18; C07D235/30; C07D401/04; C07D401/10; C07D401/12; C07D401/14; C07D403/12; C07D405/04; C07D405/12; C07D409/04; C07D409/12; C07D409/14; C07D413/04; C07D413/12; C07D417/12; C07D471/04; C07D487/04; A61K31/407; A61K31/4178; A61K31/4184; A61K31/422; A61K31/427; A61K31/428; A61K31/433; A61K31/437; A61K31/4439; A61K31/454; A61K31/4709; A61K31/4725; A61K31/496; A61K31/498; A61K31/506; A61K31/53; A61K31/5377; A61K31/541; A61K31/55; A61P1/16; A61P31/20

Domestic Patent References:

WO1997046237A1	1997-12-11
WO1997025316A1	1997-07-17

Foreign References:

EP0507650A1

1992-10-07

Other References: